The legacy of Viagra and its influence on the pharmaceutical landscape presents a thorny question for potential backers. Initially a hugely successful drug, copycat medications have significantly diminished its market dominance, creating challenges for companies participating to the original patent holder and subsequent formulas. While certain comp